AnaptysBio Inc (NASDAQ:ANAB) shares, rose in value on Friday, May 30, with the stock price down by -1.46% to the previous day’s close as strong demand from buyers drove the stock to $22.23.
Actively observing the price movement in the last trading, the stock closed the session at $22.56. Referring to stock’s 52-week performance, its high was $41.31, and the low was $12.21. On the whole, ANAB has fluctuated by 0.05% over the past month.
With the market capitalization of AnaptysBio Inc currently standing at about $653.12 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.55M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ANAB’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of ANAB currently trading nearly 8.21% and 13.05% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.33, while the 7-day volatility ratio is showing 4.45% which for the 30-day chart, stands at 3.07%. Furthermore, AnaptysBio Inc (ANAB)’s beta value is -0.25, and its average true range (ATR) is 1.33.
A comparison of AnaptysBio Inc (ANAB) with its peers suggests the former has fared considerably weaker in the market. ANAB showed an intraday change of -1.46% in last session, and over the past year, it shrunk by -4.84%%.
Data on historical trading for AnaptysBio Inc (NASDAQ:ANAB) indicates that the trading volumes over the past 3 months, they’ve averaged 738.28K. According to company’s latest data on outstanding shares, there are 30.39 million shares outstanding.
Nearly 9.88% of AnaptysBio Inc’s shares belong to company insiders and institutional investors own 128.18% of the company’s shares. The stock has risen by 67.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ANAB stock heading into the next quarter.
